Market Size of Global Thin Film Drugs Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| CAGR | 9.30 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | Low |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Thin Film Drugs Market Analysis
The thin film drug market studied was projected to grow with a CAGR of nearly 9.3% over the forecast period.
COVID-19 had a significant impact on the growth of the market during the pandemic period. The demand for thin film products was notably affected due to the launch of innovative and advanced technologies for the treatment of COVID-19 disease. For instance, in May 2022, Thin Film Freezing Pharmaceuticals delivered a platform presentation with data on stabilizing and delivering antivirals, antibodies, and vaccines using thin film freezing technology in the fight against COVID-19 and other viral infections. Thus, the pandemic outbreak led to the introduction of advanced technologies, thereby significantly impacting the market growth during the pandemic period. In addition, the demand for thin film drugs is expected to remain intact owing to the rising focus on treating various chronic disorders, thereby contributing to the market's growth over the forecast period.
The increasing prevalence of diseases such as migraine, schizophrenia, opioid dependence, and others, along with rising demand for effective thin film drugsOpioid, are expected to contribute to the market's growth. For instance, the article published by DN article in January 2022 states that 1 in 7 people worldwide suffers from migraine annually, and 14.7% of people worldwide had migraine in 2021. The same source also mentioned that around 2% of the world's population suffers from chronic migraines annually. Similarly, according to the NCBI article published in June 2022, Opioid use disorders affect over 16 million people worldwide annually. Such increasing prevalence of migraine and Opioids prevalence is expected to drive the demand for thin film drugs, thereby contributing to the market's growth.
Furthermore, the growing investments in research and development of thin film drugs are expected to boost the market growth. For instance, in November 2022, Jurata Thin Film raised initial investment funds totaling USD 4.87 million to develop the thin film drug technology. The funds raised in this investment supported the design and built a pilot-scale manufacturing line capable of fabricating over 1,000 doses of biologic-loaded thin films per hour.
However, the availability of substitute drugs is expected to hinder pharmaceutical companies' market growth over the forecast period.
Thin Film Drugs Industry Segmentation
As per the report's scope, thin film drugs have surfaced as an alternative to tablets or capsules due to their efficient therapeutic results. The drugs are made of polymers that quickly dissolve when kept in the mouth or buccal cavity, supplying the drug directly to the systemic circulation in the body. The Thin Film Drugs Market is segmented by Product Type (Oral Thin Film, Transdermal Thin Film), By Indication (Schizophrenia, Migraine, Opioid Dependence, and Others), and by geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The by eport also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (in USD million) for the above segments.
| By Product Type | |
| Oral Thin Film | |
| Transdermal Thin Film |
| By Indication | |
| Schizophrenia | |
| Migraine | |
| Opioid Dependence | |
| Others |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Global Thin Film Drugs Market Size Summary
The thin film drugs market is poised for significant growth, driven by the increasing prevalence of chronic disorders such as migraine, schizophrenia, and opioid dependence. The market's expansion is further supported by advancements in drug delivery technologies and the rising demand for effective treatment options. The COVID-19 pandemic played a pivotal role in accelerating the adoption of innovative thin film technologies, as seen in the development of antiviral and vaccine delivery systems. This trend is expected to continue as the focus on treating various chronic conditions intensifies. Additionally, substantial investments in research and development are enhancing the capabilities of thin film drug technologies, contributing to market growth.
North America is anticipated to lead the thin film drugs market, bolstered by the presence of key industry players and advanced pharmaceutical research capabilities. The region's growth is attributed to the increasing incidence of target diseases and the active involvement of market participants in strategic collaborations and partnerships. The market is moderately competitive, with major companies like ZIM Laboratories Limited, Aquestive Therapeutics, and Pfizer, Inc. playing significant roles. The ongoing development and approval of new thin film drug products are expected to further drive market expansion, as seen in recent collaborations aimed at advancing drug formulation and delivery methods.
Global Thin Film Drugs Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Rising Prevalence of Target Disorders
-
1.2.2 Increasing Investments for Pharmaceutical Developments
-
-
1.3 Market Restraints
-
1.3.1 Availability of Substitute Drugs
-
-
1.4 Porter's Five Force Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION (Market Size by Value - USD million)
-
2.1 By Product Type
-
2.1.1 Oral Thin Film
-
2.1.2 Transdermal Thin Film
-
-
2.2 By Indication
-
2.2.1 Schizophrenia
-
2.2.2 Migraine
-
2.2.3 Opioid Dependence
-
2.2.4 Others
-
-
2.3 Geography
-
2.3.1 North America
-
2.3.1.1 United States
-
2.3.1.2 Canada
-
2.3.1.3 Mexico
-
-
2.3.2 Europe
-
2.3.2.1 Germany
-
2.3.2.2 United Kingdom
-
2.3.2.3 France
-
2.3.2.4 Italy
-
2.3.2.5 Spain
-
2.3.2.6 Rest of Europe
-
-
2.3.3 Asia-Pacific
-
2.3.3.1 China
-
2.3.3.2 Japan
-
2.3.3.3 India
-
2.3.3.4 Australia
-
2.3.3.5 South Korea
-
2.3.3.6 Rest of Asia-Pacific
-
-
2.3.4 Middle East and Africa
-
2.3.4.1 GCC
-
2.3.4.2 South Africa
-
2.3.4.3 Rest of Middle East and Africa
-
-
2.3.5 South America
-
2.3.5.1 Brazil
-
2.3.5.2 Argentina
-
2.3.5.3 Rest of South America
-
-
-
Global Thin Film Drugs Market Size FAQs
What is the current Global Thin Film Drugs Market size?
The Global Thin Film Drugs Market is projected to register a CAGR of 9.30% during the forecast period (2024-2029)
Who are the key players in Global Thin Film Drugs Market?
ZIM Laboratories Limited, Aquestive Therapeutics, Indivior PLC, Tesa Labtec GmbH and Pfizer, Inc. are the major companies operating in the Global Thin Film Drugs Market.
